newsfilter
← Earnings
Earnings Releases·

OrthoPediatrics Corp. — Third Quarter 2026 Earnings Summary

OrthoPediatrics Corp. reported third-quarter 2026 total revenue of $72.7 million, representing a 19% increase year-over-year, driven by growth in Trauma & Deformity and Scoliosis product lines. The company achieved record adjusted EBITDA of $6.9 million and generated $1.6 million in free cash flow, marking a significant improvement over the prior year period. Net loss for the quarter narrowed to $5.9 million, or $0.25 per share, compared to $11.8 million in the same period of 2025. OrthoPediatrics increased its full-year 2026 revenue guidance to a range of $270.0 million to $273.0 million, anticipating breakeven free cash flow for the year.

Company
ORTHOPEDIATRICS CORP
Sector
Healthcare
Industry
Medical Devices